Specialized pro-resolution mediators in the bladder: effects of resolvin E1 on diabetic bladder dysfunction in the type 1 diabetic male Akita mouse model.

dc.contributor.author

Cervantes, Anissa

dc.contributor.author

Hughes, Francis M

dc.contributor.author

Jin, Huixia

dc.contributor.author

Purves, J Todd

dc.date.accessioned

2026-03-02T15:36:28Z

dc.date.available

2026-03-02T15:36:28Z

dc.date.issued

2024-06

dc.description.abstract

Background

One of the most common, but least studied, diabetic complication is diabetic bladder dysfunction. Current therapies include glucose control and symptom-based interventions. However, efficacy of these therapies is mixed and often have undesirable side effects. Diabetes is now known to be a chronic inflammatory disease. Specialized pro-resolving mediators are a class of compounds that promote the resolution of inflammation and have been shown to be effective in treating chronic inflammatory conditions. In this study we examine the ability of resolvin E1 to improve signs of diabetic bladder dysfunction.

Methods

Male Akita mice (Type 1 diabetic) develop hyperglycemia at 4 weeks and signs of bladder underactivity by 15 weeks. Starting at 15 weeks, mice were given one or two weeks of daily resolvin E1 and compared to age-matched wild type and untreated Akita mice.

Results

Resolvin E1 did not affect diabetic blood glucose after one week, although there was a slight decrease after two weeks. Diabetes decreased body weight and increased bladder weights and this was not affected by resolvin E1. Evan's blue dye extravasation (an indirect index of inflammation) was dramatically suppressed after one week of resolvin E1 treatment, but, surprisingly, had returned to diabetic levels after two weeks of treatment. Using cystometry, untreated Akita mice showed signs of underactivity (increased void volumes and intercontraction intervals). One week of resolvin E1treatment restored these cystometric findings back to control levels. After two weeks of treatment, cystometric changes were changed from controls but still significantly different from untreated levels, indicating a durable treatment effect even in the presence of increased inflammation at 2 weeks.

Conclusions

Resolvin E1 has a beneficial effect on diabetic bladder dysfunction in the type 1 diabetic male Akita mouse model.
dc.identifier

10.1186/s12894-024-01519-3

dc.identifier.issn

1471-2490

dc.identifier.issn

1471-2490

dc.identifier.uri

https://hdl.handle.net/10161/34241

dc.language

eng

dc.publisher

Springer Science and Business Media LLC

dc.relation.ispartof

BMC urology

dc.relation.isversionof

10.1186/s12894-024-01519-3

dc.rights.uri

https://creativecommons.org/licenses/by-nc/4.0

dc.subject

Animals

dc.subject

Mice, Inbred C57BL

dc.subject

Mice

dc.subject

Diabetes Mellitus, Experimental

dc.subject

Diabetes Mellitus, Type 1

dc.subject

Disease Models, Animal

dc.subject

Eicosapentaenoic Acid

dc.subject

Male

dc.subject

Urinary Bladder

dc.subject

Urinary Bladder Diseases

dc.title

Specialized pro-resolution mediators in the bladder: effects of resolvin E1 on diabetic bladder dysfunction in the type 1 diabetic male Akita mouse model.

dc.type

Journal article

duke.contributor.orcid

Hughes, Francis M|0000-0003-3776-3653

duke.contributor.orcid

Purves, J Todd|0000-0001-9689-2047

pubs.begin-page

130

pubs.issue

1

pubs.organisational-group

Duke

pubs.organisational-group

School of Medicine

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Pediatrics

pubs.organisational-group

Urology

pubs.publication-status

Published

pubs.volume

24

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
DBD and RvE1-Published.pdf
Size:
1.25 MB
Format:
Adobe Portable Document Format